期刊文献+

多西他赛两种剂型在beagle犬体内基本药代动力学的比较研究 被引量:3

Basic pharmacokinetics comparative study of two different preparations of docetaxel in beagle dogs
原文传递
导出
摘要 目的建立beagle犬血浆中及SD大鼠组织中多西他赛的浓度测定方法,并对新剂型及原有剂型多西他赛药代动力学及组织分布特点进行比较。方法采取双处理、两周期随机交叉的实验设计,观察了在相同剂量(1.0或2.5 mg/kg)下注射用多西他赛和原剂型多西他赛注射液在beagle犬体内的药代动力学差异;观察了两种剂型在大鼠组织中分布的差异;建立了液相色谱-三重串联四级杆质谱联用(QQQ LC-MS)法,测定不同时间的两种剂型多西他赛血浆浓度。结果血浆样品在2~500μg/L范围内呈线性,最低检测限为2μg/L。血浆药物浓度在5、50和500μg/L,日间精密度分别为3.9%、7.0%和5.3%,回收率范围为89.2%~101.1%。血浆样品3日内,萃取样品3个月内稳定性良好。新剂型与原有剂型的药代动力学重要参数差异均有统计学意义(P<0.05),组织学分布可观察到差异。结论建立方法灵敏可靠,满足测定要求。与原剂型相比,在相同剂量下新剂型在血浆中的暴露较低,但是在组织器官中的分布更多,尤其在肺脏中分布更多,持续时间更长。 Objective To establish a liquid chromatography tandem mass spectrometric method for determination of docetaxel in bio-samples and to compare the pharmacokinetic parameters and tissue distribution between novel preparation and original preparation.Methods Two-treatment and two-period random cross-over design were used in this study.Two preparations of deocetaxel were given to beagle dogs at the doses of 1.0 or 2.5 mg/kg.The differences in indicators of pharmacokinetics were observed between treatment groups.And the method of liquid chromatography QQQ mass spectrometric(QQQ LC-MS) was established to detect the blood docetaxel concentration in different periods.Results Docetaxel concentration was linear over the range of 2-500 μg/L and the limit qualification was 2μg/L.The intra-day precision(RSD) ranged from 3.9% to 7.0%.Extraction recovery was above 89.2% for the concentration of 5,50,500 μg/L of samples respectively.The difference of pharmacokinetic parameters and tissue distribution between two preparations were significant.Conclusion The established method was sensitive,fast and simple.The novel preparation was shown lower exposure in plasma while higher exposure in tissue than the original one,especially in lungs.
出处 《毒理学杂志》 CAS CSCD 北大核心 2011年第4期252-256,共5页 Journal of Toxicology
关键词 多西他赛 高效液相色谱-质谱联用法 药代动力学 组织分布 Docetacel Liquid chromatography QQQ mass spectrometric(QQQ LC-MS) Pharmacokinetics Tissue distribution
  • 相关文献

参考文献11

  • 1宋沁馨,于立洁.多西他赛的临床应用进展[J].中国新药杂志,2001,10(12):900-903. 被引量:18
  • 2王玉洁,柴艳冬,戴晓雁,达超亮,严红艳,李世唐,吴海盼,张燕.多西他赛主要不良反应及处理对策[J].甘肃医药,2009,28(4):263-264. 被引量:4
  • 3李欣,刘燕,康艳敏,梅兴国.高效液相色谱法测定多西紫杉醇静脉纳米乳剂的含量[J].解放军药学学报,2007,23(1):32-34. 被引量:6
  • 4Rouini MR, Lotfolahi A, Stewart DJ, et al. A rapid reversed phase high performance liquid chromatographic method for the determination of docetaxel (Taxotere) in human plasma using a column switching technique [ J ]. J Pharm Biomed Anal, 1998, 17(8) :1243-1247.
  • 5Daniel LG, Michael E. Analysis of docetaxel pharmacokinetics in humans with the inclusion of later sampling time-points afforded by the use of a sensitive tandem LCMS assay [ J]. Cancer Chemother Pharmacol, 2003,52(2) : 159-166.
  • 6Heleen AB, Arjan BGHR, Michel JXH,et al. Metabolism of docetaxel in mice [ J ]. Cancer Chemother Pharmacol, 2005,56 ( 3 ) : 299-306.
  • 7Hou WY, James W. Watters, Howard L. McLeod. Simple and rapid docetaxel assay in plasma by protein precipitation and high--performance liquid chromatography--tandem mass spectrometry [ J ]. J Chromatogr B ,2004,804 ( 2 ) :263-267.
  • 8高坤,陈凤菊,孙进,何仲贵.高效液相色谱-质谱联用法测定大鼠血浆中多西他赛的含量[J].沈阳药科大学学报,2008,25(6):462-466. 被引量:6
  • 9Anders A, David JW. High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquidchromatography with UV detection [J]. BMC Clinical Pharmacology. 2006:6 ( 2 ) : 1-10.
  • 10范博,周建平,仝新勇,谭燕,陈亮,王影,胡晶晶.液相色谱-质谱联用法考察多西他赛脂质体犬体内药动学[J].中国新药与临床杂志,2007,26(5):367-370. 被引量:10

二级参考文献35

  • 1郝学志,张湘茹,孙燕,多西他赛临床研究协作组.国产多西他赛治疗乳腺癌和非小细胞肺癌的临床观察[J].中国肿瘤临床,2005,32(18):1064-1066. 被引量:24
  • 2宋海平,徐建华,王淑琳,李炳荣.多西他赛联合顺铂治疗晚期非小细胞肺癌26例[J].中国新药与临床杂志,2006,25(2):141-143. 被引量:3
  • 3惠双.多西紫杉醇致重度致死性水肿1例[J].中国煤炭工业医学杂志,2006,9(4):317-317. 被引量:5
  • 4何红梅,刘贤称.多西他赛不良反应观察及处理[J].交通医学,2006,20(5):616-616. 被引量:3
  • 5Rowinsky EK.The development and clinical utility of the taxane class of antimicrotubule chemotherapy agents[J].Annu Rev Med,1997,48:353.
  • 6Weiss RB,Donehower RC,Wiemik PH,et al.Hypersensitivity reactions from Taxol[J].J Clin Oncol,1990,8(7):1263.
  • 7HERBST RS,KHURI FR.Mode of action of docetaxel--a basis for combination with novel anticancer agents[J].Cancer Treat Rev,2003,29(5):407-415.
  • 8IMMOTDINO ML,BRUSA P,ARPICCO S,et al.Preparation,characterization,cytotoxicity and pharmacokinetics of liposomes containing docetaxel[J].J Control Release,2003,91 (3):417-429.
  • 9HOU WY,WATTERS JW,MCLEOD HL.Simple and rapid docetaxel assay in plasma by protein precipitation and high-performance liquid chromatography-tandem mass spectrometry[J].J Chromatogr B,2004,804(2):263-267.
  • 10BISSERY M C, GUENAR D, GUERITTE-VOEGELEIN F, et al. Experimental antitumor activity of taxotere (RP 56976, NSC 628503), a taxol analogue [ J ]. Cancer Res, 1991, 51 (18):4845 - 4852.

共引文献36

同被引文献25

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部